UZ Gent

Futó vizsgálatok

• Toboroz

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· 3. fázis· Forrás

• Toboroz

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· 3. fázis· Forrás

• Toboroz

  Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study

  NCT07799974· Forrás

• Toboroz

  A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  NCT07492680· 2. fázis· Forrás

• Még nem toboroz

  Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The Colorectal Regular-Irregular Score

  NCT07584486· Forrás

• Toboroz

  A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  NCT07483099· 2. fázis· Forrás

• Toboroz

  LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

  NCT06831955· 2. fázis· Forrás

• Toboroz

  Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer

  NCT06962137· 2. fázis· Forrás

• Toboroz

  Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

  NCT06925984· Forrás

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Forrás

• Toboroz

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· 2/3. fázis· Forrás

• Toboroz

  Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis

  NCT07029152· Forrás

• Toboroz

  A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

  NCT07047144· 2. fázis· Forrás

• Toboroz

  A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

  NCT06523374· Forrás

• Toboroz

  Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

  NCT06719440· Forrás

• Toboroz

  The Dragon PLC Trial (DRAGON-PLC)

  NCT06914648· Forrás

• Toboroz

  Immuno-virological Evaluation of Persons Living With HIV (PLWH)

  NCT05973825· Forrás

• Fut, nem toboroz

  A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT06686615· Forrás

• Toboroz

  Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

  NCT06523634· Forrás

• Toboroz

  Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable

  NCT06193356· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Forrás

• Toboroz

  A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  NCT05980806· 2. fázis· Forrás

• Fut, nem toboroz

  A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

  NCT06245408· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer

  NCT06052332· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  NCT06004245· 1. fázis· Forrás

• Toboroz

  Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

  NCT06282588· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

  NCT05993234· Forrás

• Toboroz

  A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support

  NCT05913622· Forrás

• Toboroz

  Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

  NCT04954599· 1/2. fázis· Forrás

• Toboroz

  Liquid Biopsies in Esophageal Cancer

  NCT05704530· Forrás

• Meghívásos bevonás

  Validation of the Global Polypectomy Assessment Tool (GPAT)

  NCT05877456· Forrás

• Fut, nem toboroz

  A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

  NCT05668988· 3. fázis· Forrás

• Toboroz

  Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

  NCT05491525· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· 3. fázis· Forrás

• Toboroz

  A Novel Clinical Decision Support Tool to Predict Submucosal Invasive Cancer Within Large Non-Pedunculated Colorectal Polyps

  NCT07705880· Forrás

• Toboroz

  Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

  NCT05169593· 4. fázis· Forrás

• Fut, nem toboroz

  Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy

  NCT05365568· Forrás

• Fut, nem toboroz

  Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

  NCT05270044· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· 3. fázis· Forrás

• Toboroz

  The DRAGON 2 Trial

  NCT05428735· Forrás

• Fut, nem toboroz

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· 3. fázis· Forrás

• Toboroz

  Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

  NCT04991948· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

  NCT04975308· 3. fázis· Forrás

• Fut, nem toboroz

  Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

  NCT05059522· 3. fázis· Forrás

• Toboroz

  A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  NCT04844606· 3. fázis· Forrás

• Toboroz

  DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

  NCT07717437· Forrás

• Fut, nem toboroz

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Forrás

• Toboroz

  Long-term Better Than Short-term ADT With Salvage RT

  NCT04242017· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· 3. fázis· Forrás

Showing 50 of 58.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák8 toboroz
• Prosztatarák4 toboroz
• Crohn-betegség3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• HIV-fertőzés3 toboroz
• Máj- és epeúti rák3 toboroz
• Fej-nyaki daganatok2 toboroz
• Hasnyálmirigyrák2 toboroz
• Tripla negatív emlőrák2 toboroz
• Tüdőrák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Arthritis psoriatica1 toboroz
• Áttétes emlőrák1 toboroz
• Colitis ulcerosa1 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Melanóma1 toboroz
• Mielóma multiplex1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Petefészekrák1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Zsírmáj (MASLD/MASH)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

  NCT06595563· 2. fázis· Forrás

• Lezárult

  A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage

  NCT05970224· 2. fázis· Forrás

• Lezárult

  Visual Perturbation Training to Reduce Fall Risk in People with Parkinson's Disease

  NCT05690308· Forrás

• Lezárult

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· 2. fázis· Forrás

• Lezárult

  Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study

  NCT05569291· Forrás

• Lezárult

  Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

  NCT05232071· 2. fázis· Forrás

• Lezárult

  Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

  NCT05156320· 3. fázis· Forrás

• Lezárult

  Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

  NCT04671433· 3. fázis· Forrás

• Lezárult

  A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

  NCT04238819· 1/2. fázis· Forrás

• Visszavonták

  BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

  NCT04231929· Forrás

• Lezárult

  Long-term Activity Coaching in Patients With COPD

  NCT04139200· Forrás

• Lezárult

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· 2. fázis· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

  NCT04166773· 2. fázis· Forrás

• Leállították

  IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study

  NCT03705403· 2. fázis· Forrás

• Lezárult

  A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

  NCT03783442· 3. fázis· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Forrás

• Leállították

  Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

  NCT02863055· 2. fázis· Forrás

• Lezárult

  A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

  NCT03289962· 1. fázis· Forrás

• Lezárult

  A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

  NCT03301220· 3. fázis· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Forrás

• Lezárult

  Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex

  NCT03180736· 3. fázis· Forrás

• Lezárult

  A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

  NCT03106324· Forrás

• Lezárult

  Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

  NCT02913482· 2. fázis· Forrás

• Lezárult

  Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

  NCT02898610· 3. fázis· Forrás

• Lezárult

  ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

  NCT02891824· 3. fázis· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Forrás